Navigation Links
Recombinant C-Reactive Protein

ST. LOUIS, May 7 /PRNewswire/ -- Lee Biosolutions has announced that it will increase its C-Reactive Protein product line to include recombinant C-Reactive Protein.

C-Reactive Protein is a protein found in the blood that operates as a marker for inflammation, meaning its presence indicates an increased state of inflammation in the body. Inflammation is a normal response to a number of physical states including injury, fever and infection. Inflammation is also believed to play a role in the initiation and progression of cardiovascular disease.

r-hCRP is produced into culture medium by DNA recombinant procedure in E. Coli as secretory protein. By expressing kil gene, the outer membrane of E. Coli becomes permeable, allowing recombinant C-Reactive Protein to be excreted without cell lysis. r-hCRP has similar biological property in terms of Ca2+-binding ability to the native protein, and is purified by affinity chromatography. N-terminal amino acid sequence of r-hCRP is the same as that of the native human c-reactive protein.

According to Lee Biosolutions President Burton Lee, the company pays close

attention to the clinical research community to stay ahead of their demands for acute phase proteins like C-Reactive Protein CRP . Lee Biosolution now has canine, rat, human and recombinant c-reactive protein.

    Press Release Contact Information:
    Burton Lee
    Lee Biosolutions, Inc

This release was issued through WebWire(R). For more information visit

SOURCE Lee Biosolutions, Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Richter-Helm and Athera Biotechnologies Partner in Development of Recombinant Protein to Treat Cardiovascular Disease
2. PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
3. New Recombinant XYNTHA Now Available for Patients with Hemophilia A
4. Deloitte Agrees to Acquire Recombinant Capital, A Leading Life Sciences Subscription Database and Advisory Services Firm
5. Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3)
6. Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies
7. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
8. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
9. Recombinant Human Renin - Crystallographic Grade
10. Protein Sciences Announces Signing of a Forbearance Agreement With Emergent BioSolutions
11. Xennex Inc. Providing Satoris Inc. with Latest GeneCards(R) Tools for Characterization of Protein Biomarkers Associated With Neurological Conditions
Post Your Comments:
(Date:10/12/2015)... , October 12, 2015 cell surface ... billion by 2022, according to a new report by Grand ... to rise in incidence of oncology diseases and other cell-associated ... is expected to reach USD 6.49 billion by 2022, according ... growth in demand can be attributed to rise in incidence ...
(Date:10/12/2015)... CAESAREA, Israel , October 12, 2015 ... of the Dario™ Diabetes Management Solution, today announced its ... a patient case study at MobiHealth,s 5th EAI ... Focused on, "Transforming healthcare through innovations in mobile and ... London, England from October 14 - ...
(Date:10/12/2015)... ... October 12, 2015 , ... NeuMedics Inc., is a specialty ... diseases that can safely and chronically be administered as an eye drop, announced today ... by The Cleveland Clinic and taking place October 25th to October 28th at The ...
(Date:10/10/2015)... Maryland , 10. Oktober, 2015 ... Matsui (Abgeordnete der Demokratischen Partei für Kalifornien) ihre ... bis 17. Oktober) in die Aufzeichnungen des Kongresses ... Plasma Protein Therapeutics Association (PPTA) und ihren ... , Hebung des Bewusstseins über Plasmaspenden weltweit ...
Breaking Biology Technology:
(Date:9/24/2015)... , September 24, 2015 ... september 2015 Kerv ( ... finanstjänster, lanserar idag världens första kontaktlösa betalningsring ... in 77 000 GBP för massproduktion via ... ) , Kerv-bärare kan ...
(Date:9/10/2015)... -- Pursuant Health has collaborated with health experts ... image-based health risk assessment (HRA) optimized for Pursuant ... assessment quantifies user results into an easily understood ... biological age based on personal health habits, characteristics ... Comprised of age, gender, and risk ...
(Date:9/8/2015)... Sept. 8, 2015  Affectiva, global leader in ... a Service, a new data solution, and version ... on Affectiva,s highly accurate and patented science, these ... slated to transform industries such as market research, ... customer experience, online education, HR, automotive, robotics, healthcare ...
Breaking Biology News(10 mins):